trial · primary record
HT-102
Chronic Hepatitis B
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2024-06-18 |
| Primary endpoint | Number of Participants With Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT06744686 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:12.312Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06744686
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.